Skip to main content
Erschienen in: Supportive Care in Cancer 12/2016

26.07.2016 | Original Article

Safety, efficacy, and patient-perceived satisfaction of peripherally inserted central catheters in terminally ill cancer patients: a prospective multicenter observational study

verfasst von: Kwonoh Park, Hyun Jung Jun, So Yeon Oh

Erschienen in: Supportive Care in Cancer | Ausgabe 12/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The purpose of this study was to investigate the safety, efficacy, and subjective satisfaction of peripherally inserted central catheters (PICCs) in terminally ill cancer patients.

Methods

All PICCs were inserted by an interventional radiologist with radiological guidance. We monitored the occurrence of PICC-related complication and evaluated the patient-perceived satisfaction for PICC using semi-structured questionnaire.

Results

A total of 36 terminally ill cancer patients underwent PICC. Three patients had 2 PICC insertions; hence, finally 39 episodes during 829 PICC days were analyzed. All procedures were completed without any procedure-related complication. The median catheter life span was 19.0 days (95 % CI, 14.1–23.9). Thirty-four cases maintained the PICC until the intended time, while the other 5 cases (12.8 %; 6.1/1000 PICC days) were premature PICC removals. Totally 10 complications (25.6 %; 12.3/1000 PICC days) were reported including premature removals (n = 5), trivial bleedings (n = 3), and thrombophlebitis (n = 2). Patients reported that the procedure was not distressing (42 %), a little distressing (36 %), or distressing (21 %). Of 30 patients who had preserved cognitive function at fifth day, most patients (n = 25, 83 %) reported more comfort although the other 5 patients reported no change (n = 3) or less comfort (n = 2).

Conclusions

PICCs were safely inserted and showed favorable maintenance rate with acceptable complications. Additionally, most of the patients felt that parenteral access became much comfortable after PICC insertion. When considering the characteristics of terminally ill cancer patients, poor general condition and a limited period of survival, PICC could be a safe and effective method for intravenous access.
Literatur
3.
Zurück zum Zitat Walshe LJ, Malak SF, Eagan J, Sepkowitz KA (2002) Complication rates among cancer patients with peripherally inserted central catheters. J Clin Oncol Off J Am Soc Clin Oncol 20(15):3276–3281CrossRef Walshe LJ, Malak SF, Eagan J, Sepkowitz KA (2002) Complication rates among cancer patients with peripherally inserted central catheters. J Clin Oncol Off J Am Soc Clin Oncol 20(15):3276–3281CrossRef
5.
Zurück zum Zitat Smith JR, Friedell ML, Cheatham ML, Martin SP, Cohen MJ, Horowitz JD (1998) Peripherally inserted central catheters revisited. Am J Surg 176(2):208–211CrossRefPubMed Smith JR, Friedell ML, Cheatham ML, Martin SP, Cohen MJ, Horowitz JD (1998) Peripherally inserted central catheters revisited. Am J Surg 176(2):208–211CrossRefPubMed
6.
Zurück zum Zitat Gunst M, Matsushima K, Vanek S, Gunst R, Shafi S, Frankel H (2011) Peripherally inserted central catheters may lower the incidence of catheter-related blood stream infections in patients in surgical intensive care units. Surg Infect 12(4):279–282. doi:10.1089/sur.2008.058 CrossRef Gunst M, Matsushima K, Vanek S, Gunst R, Shafi S, Frankel H (2011) Peripherally inserted central catheters may lower the incidence of catheter-related blood stream infections in patients in surgical intensive care units. Surg Infect 12(4):279–282. doi:10.​1089/​sur.​2008.​058 CrossRef
8.
Zurück zum Zitat Park K, Lim HG, Hong JY, Song H (2014) Safety and efficacy of peripherally inserted central catheters in terminally ill cancer patients: single institute experience. Korean J Hosp Palliat Care 17(3):179–184CrossRef Park K, Lim HG, Hong JY, Song H (2014) Safety and efficacy of peripherally inserted central catheters in terminally ill cancer patients: single institute experience. Korean J Hosp Palliat Care 17(3):179–184CrossRef
9.
Zurück zum Zitat Morita T, Tei Y, Tsunoda J, Inoue S, Chihara S (2001) Underlying pathologies and their associations with clinical features in terminal delirium of cancer patients. J Pain Symptom Manag 22(6):997–1006CrossRef Morita T, Tei Y, Tsunoda J, Inoue S, Chihara S (2001) Underlying pathologies and their associations with clinical features in terminal delirium of cancer patients. J Pain Symptom Manag 22(6):997–1006CrossRef
10.
Zurück zum Zitat Lundh Hagelin C, Seiger A, Furst CJ (2006) Quality of life in terminal care--with special reference to age, gender and marital status. Support Care Cancer : Off J Multinational Assoc Support Care Cancer 14(4):320–328. doi:10.1007/s00520-005-0886-4 CrossRef Lundh Hagelin C, Seiger A, Furst CJ (2006) Quality of life in terminal care--with special reference to age, gender and marital status. Support Care Cancer : Off J Multinational Assoc Support Care Cancer 14(4):320–328. doi:10.​1007/​s00520-005-0886-4 CrossRef
11.
Zurück zum Zitat Lee GJ, Ahn HS, Go SE, Kim JH, Seo MW, Kang SH, Yang YR, Lee MY, Lee KO, Chun SH, Jin JY (2015) Patient’s factors at entering hospice affecting length of survival in a hospice center. Cancer Res Treatment : Off J Korean Cancer Assoc 47(1):1–8. doi:10.4143/crt.2013.148 CrossRef Lee GJ, Ahn HS, Go SE, Kim JH, Seo MW, Kang SH, Yang YR, Lee MY, Lee KO, Chun SH, Jin JY (2015) Patient’s factors at entering hospice affecting length of survival in a hospice center. Cancer Res Treatment : Off J Korean Cancer Assoc 47(1):1–8. doi:10.​4143/​crt.​2013.​148 CrossRef
12.
Zurück zum Zitat Llobera J, Esteva M, Rifa J, Benito E, Terrasa J, Rojas C, Pons O, Catalan G, Avella A (2000) Terminal cancer. Duration and prediction of survival time. Eur J Cancer (Oxford, England : 1990) 36(16):2036–2043CrossRef Llobera J, Esteva M, Rifa J, Benito E, Terrasa J, Rojas C, Pons O, Catalan G, Avella A (2000) Terminal cancer. Duration and prediction of survival time. Eur J Cancer (Oxford, England : 1990) 36(16):2036–2043CrossRef
13.
14.
Zurück zum Zitat Sansivero GE (2000) The microintroducer technique for peripherally inserted central catheter placement. Journal of intravenous nursing : the official publication of the intravenous nurses society 23 (6):345–351 Sansivero GE (2000) The microintroducer technique for peripherally inserted central catheter placement. Journal of intravenous nursing : the official publication of the intravenous nurses society 23 (6):345–351
16.
Zurück zum Zitat Li J, Fan YY, Xin MZ, Yan J, Hu W, Huang WH, Lin XL, Qin HY (2014) A randomised, controlled trial comparing the long-term effects of peripherally inserted central catheter placement in chemotherapy patients using B-mode ultrasound with modified Seldinger technique versus blind puncture. Eur J Oncol Nurs 18(1):94–103. doi:10.1016/j.ejon.2013.08.003 CrossRefPubMed Li J, Fan YY, Xin MZ, Yan J, Hu W, Huang WH, Lin XL, Qin HY (2014) A randomised, controlled trial comparing the long-term effects of peripherally inserted central catheter placement in chemotherapy patients using B-mode ultrasound with modified Seldinger technique versus blind puncture. Eur J Oncol Nurs 18(1):94–103. doi:10.​1016/​j.​ejon.​2013.​08.​003 CrossRefPubMed
19.
Zurück zum Zitat Mermel LA (2000) Prevention of intravascular catheter-related infections. Ann Intern Med 132(5):391–402CrossRefPubMed Mermel LA (2000) Prevention of intravascular catheter-related infections. Ann Intern Med 132(5):391–402CrossRefPubMed
Metadaten
Titel
Safety, efficacy, and patient-perceived satisfaction of peripherally inserted central catheters in terminally ill cancer patients: a prospective multicenter observational study
verfasst von
Kwonoh Park
Hyun Jung Jun
So Yeon Oh
Publikationsdatum
26.07.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 12/2016
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-016-3360-6

Weitere Artikel der Ausgabe 12/2016

Supportive Care in Cancer 12/2016 Zur Ausgabe

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.